American International Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

American International Group’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,898	Closed	-$50K	–	3357
2022 Q1	$50K	Sell	7,898 -555	-7%	-$3.48K	﹤0.01%	2844
2021 Q4	$94K	Sell	8,453 -254	-3%	-$3.52K	﹤0.01%	2745
2021 Q3	$142K	Sell	8,707 -92	-1%	-$1.65K	﹤0.01%	2628
2021 Q2	$163	Buy	8,799 +5,050	+135%	+$97K	﹤0.01%	2636
2021 Q1	$57	Buy	3,749 +521	+16%	+$11.3K	﹤0.01%	2954
2020 Q4	$104	Buy	+3,228	New	+$42.7K	﹤0.01%	2647

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

American International Group's CDAK Position: Q2 2022 in Review

American International Group sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2022, closing a stake of 7,898 shares — an estimated $50K sold.

American International Group first reported a position in CDAK in Q4 2020 and held it in 6 quarters. The position peaked at $142K in Q3 2021. 49 funds tracked by Wall St. Rank hold CDAK as of Q2 2022.

American International Group reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
American International Group sold 7,898 Codiak BioSciences, Inc. Common Stock shares in Q2 2022, an estimated $50K.
American International Group first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
American International Group's Codiak BioSciences, Inc. Common Stock position peaked at $142K in Q3 2021.
49 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.